CAD, MI (ACS) Flashcards

drugs for IHD (ischemic heart disease)

1
Q

IHD- ischemic heart ds
- 2 types

A

Angina Pectoris and MI (ACS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Angina Pectoris
- types

A

Typical v. Variant/Atypical

typical:
- stable: attack occurs w exertion, relieve w rest, occur under same circumstances
- unstable: attack inc in freq and severity

variant/atypical:
- prinzmetal/vasospastic: due to acute coronary vasospasm, occurs during rest or sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

angina characteristics
- where, radiation, how is it induced

A

substernal or left precordial pain
- radiate to L shoulder
- induced by exercise or cold temps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

goals for tx angina

A

inc our O2 supply (BB, CCB, vasodilators)
dec myocardial O2 demand
(BB and CCB to dec HR, CO, and contractility)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

tx typical vs. atypical angina

A

typical- stable angina first line is BB

atypical- prinzmetal first line is CCB (DO NOT GIVE BB, it cannot counteract vasospasm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

adjunct tx

A

stabilize atherosclerotic plaques to prevent ACS
manage modifiable RFs
- HTN, HLD, DM, smoking cessation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

non pharm tx

A

PCI and CABG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ANGINA

beta blockers
- names and categories

A

B1 selective: metoprolol, atenolol, nebivolol (M.A.N)

non selective: propanolol, nadolol

a1/B blockers: carvedilol, labetalol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ANGINA

Beta Blockers
- MOA
- indications
- CI

A

-olol
- first line for typical angina if no CI

MOA- dec HR, BP, CO, and myocardial O2 demand

Indications- HTN, CHF, typical angina, Mi, certain arrythmias, migraine

NOT FOR PRINZMETALS ANGINA or ACUTE angina attack

CI- sinus bradycardia, SBP <100, heart block, cardiogenic shock
- selective agents CI in COPD, asthma, DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ANGINA

Beta Blockers
- ADRs
- DDIs
- monitoring parameters

A

ADRs- hypotension, bradycardia, bronchospasm, hypercholesteremia

DDIs- verapamil (dec CO and contractility too much)

monitor- BP, HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ANGINA

CCBs
- names and categories

A

Non-DHPs (Central acting)
- verapamil, diltiazem

DHPs (peripheral acting)
- amlodipine, nifedipine, felopdipine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ANGINA

CCBs
- MOA
- indications
- CI

A

MOA- smooth muscle relaxation, suppress cardiac activity, inc O2 supply/dec myocardial O2 demand

indications- HTN, angina (prinzmetals), arrhythmias (central acting)

CI- SBP <100, Hr <60, EF <40% (neg inotrope bad for HFrEF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ANGINA

CCBs
- ADRs
- DDI
- monitoring

A

ADRs- constipation, bradycardia, flushing, reflex tachy, periph edema
- CHF, heart block, hypotension w CENTRAL acting

DDI- dixgoxin, amiodarone, azoles (w verap and diltiaz)

monitor- BP, HR, EKG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ANGINA

CCB in angina management
when to use:
- DHP initial tx?
- other use for DHP
- combo with?
- non DHP for?

A
  • use DHP as initial tx when BB are CI
  • DHP as add on therapy to BB
  • combo w nitrates
  • non DHP for atypical/prinzmetal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ANGINA

organic nitrites and nitrates
- names and routes

A

amyl nitrates (INH), nitroglycerin (IV, PO, SL, buccal, topical, transdermal), isosorbide (PO, SL), Ranolazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ANGINA

nitrites and nitrates
- MOA
- higher doses ?
- indications
- CI

A

MOA- release NO to dec preload, ventricular diastolic vol, ventricular pressure and myocardial wall tension & O2 demand
- higher doses: can dec LV afterload

indications- angina (that persists w monotherapy), MI, CHF

CI- aortic valve stenosis, concurrent use w sildenafil/tadalafil (for PAH and ED), close angle glaucoma, severe hypotension and anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ANGINA

nitrites/nitrates
- ADRs
- DDI
- monitoring

A

ADRs- tolerance develops, syncope, orthostat hypotension
- overdose—> reflex tachy and arrhythmias

DDIs- PDE 5 inhibitors (sildenafil), isosorbide is CYP3A4 substrate

monitor- BP, HR

18
Q

ANGINA

nitrites/nitrates
- role in angina managment

A

SL formulation to relieve acute SS of Myocardial Ischemia
- SUBLINGUAL NITRO IS IMMEDIATE EFFECTIVE

SL/PO to prevent effort induced angina
- prophylaxis

long acting for maintenance tx

19
Q

ANGINA

nitrites/nitrates
- Amyl Nitrate
- onset, DOA, use

A
  • rapid onset, brief DOA
  • used for cyanide poisoning
20
Q

angina

nitrites/nitrates
- nitroglycerin
- SL, buccal ointment, patch, PO, IV uses

A
  • SL and buccal- deteriorates in sunlight, replace bottle 3-6 month after opening
  • ointment- nitrobid 2%
  • patch- several doses
  • PO- administer QD or BID to minimize tolerance
  • IV- contains propylene glycol, need special tubing
21
Q

ANGINA

nitrites/nitrates
- Isosorbide
- dinitrate v. mononitrate

A

dinitrate- PO or SL, give TID (8am, 1, 6)
mononitrate- Po only, longer acting
- ismo BID 7 hrs apart
- imdur QD

22
Q

ANGINA

Ranolazine
- MOA
- CI
- Precautions

A

MOA- sodium current inhibitor
Indications- chronic stable angina in combo w CCB, BB, or nitrates

CI- pre existing QT prolongation, uncorrected hypokalemia, hepatic failure , potent CYP3A4 inhibitors

precaution- can prolong QT, induce torsades de pointe!!!!!!!!!!!!

ranolazine will PROLONG QT

23
Q

ANGINA

ranolazine
- ADRs
- DDIs

A

ADRs- dizzy, HA, constipation, PROLONGS QT INTERVAL
(less HR/BP effect than other classes)
DDIs- CYP450 substrate

24
Q

ANGINA

adjunct tx for angina
- categories

A

antiplatelet drugs, ACEi, and optimizing RFs

25
Q

ANGINA

adjunct tx- Antiplatelet
- use in what pts?

A

Aspirin
- prevents platelet aggregation and thrombosis
- used to prevent ACS in UNSTABLE ANGINA PTS

other agents:
- clopidogrel, prasugrel, ticagrelor

optimize modifiable RFs

26
Q

ANGINA management overview
- asthma
- DM
- HF
- HTn
- prior MI
- bradycardia/heart block

A
  • asthma: non DHP/central CCB or cardioselective BB
  • DM: non DHP CCB, nitrates/cardioselective BB alternative
  • HF: BB and nitrates, nonDHP CCB least preferred
  • HTN: BB and Non DHP CCB
  • prior MI: BB
  • bradycardia/heart block: DHP CCB
27
Q

ACUTE STEMI

Acute STEMI pharm tx
-names

A

CAMONABAS
- CCB
- ACEi
- morphine/analgesics
- Oxygen
- NTG IV
- Aspirin
- BB
- Anticoag (UFH, LMWH)
- Statins

additional
- (P2y-12 inhibitors) antiplatelet agents/thrombolytics - clopidogrel, prasugrel
- fibrinolytics
- PCI

28
Q

ACUTE STEMI

CCBs
- which CCB
- indicated for what kind of pts

A
  • do NOT affect morbidity and mortality
  • give to pts intolerant to BB
  • diltiazem (pts w non Q wave Mi w out LV dysfunction)
29
Q

ACUTE STEMI

ACEi
- indicated for what pts

A

recc for all post MI pts with LV dysfunction or CHF

30
Q

ACUTE STEMI

Morphine/analgesics

A

IV morphine for pain relief if NTG did not alr relieve pain

31
Q

ACUTE STEMI

NTG
- when should it be administered
- purpose

A

IV NTG recc for first 24-48 hrs of acute MI
- do NOT give if SBP <90 or HR <40
- alleviates ischemic myocardial pain

32
Q

ACUTE STEMI

Aspirin
- when to administer
- what pts
- freq

A
  • antiplatelet
  • use for all MI pt unless CI
  • start ASAP, continue indefinitely
33
Q

ACUTE STEMI

BB
- when to administer
- freq continued

A
  • start IV dose ASAP, continue post Mi with PO unless CI
  • reduces morbid/mortality
34
Q

Anticoag/UFH or LMWH

A

duration of tx depends on type of reperfusion
UFH, LMWH (10a inhib)

35
Q

ACUTE STEMI

Statins

A

start pt on statins post MI for long term reduction CV events, morbidity, and mortality

36
Q

ACUTE STEMI

P2Y-12 inhibitiors/antiplatelet agents

dose and duration?

A
  • clopidogrel, prasugrel, ticagrelor
  • dose and duration depends on revasc therapy (PCTA/PCI - DES vs. BMS)
  • continued as DAPT for maintenance (dual antiplatelet therapy)

DES- 12 month DAPT
BMS- 1 month min to 12 month DAPT

37
Q

ACUTE STEMI

reperfusion- fibrinolytics
- what do they do
- MOA
- types
- CI (absolute v. relative)

A
  • acheive RAPID thrombolysis
  • plasminogen activators dissolve existing clots
  • types: streptokinase, alteplase, reteplase

absolute CI—> previous hemorrhagic stroke, other CVA within 1 yr, incranial neoplasm, suspected aortic dissection
relative CI—> uncontrolled HTN, recent trauma or internal bleeding,m pregnancy, PUD, hx chronic severe HTN

38
Q

ACUTE STEMI

Reperfusion PCI vs. Fibrinolytics

A
  • if hospital has PIC capability, treat w primary PCI within 90 mins of medical contact
  • if no PCI and cannot be transfered to hopsital w PCI within 90 mins, tx with fibrinolytics within 30 mins in hospital unless CI
39
Q

ACUTE STEMI

PCI

A
  • stent placement
  • some pts require CABG
40
Q

ACUTE STEMI

if pt requires CABG, what must you stop

A

must stop antiplatelets for 5-7 days if possible

41
Q

major diff in tx stemi vs nstemi?

A

NSTEMI– fibrinolytics are NOT USED